GR4VY LIMITED


Directors	LUNN, John
	MINAEI MOGHADAM, Ali


Registered Address	Spaces Baker Street 83 - 85 Baker Street
	Marylebone
	London
	W1U 6AG


Registered Number	12966015 (England and Wales)

Balance Sheet as at
31 December 2025

	2025		2024
	£	£	£	£
Fixed assets
Tangible assets		35,796		37,801
		35,796		37,801
Current assets
Debtors	1,946,265		1,756,801
Cash at bank and on hand	8,002		177
	1,954,267		1,756,978
Creditors amounts falling due within one year	(174,423)		(65,645)
Net current assets (liabilities)		1,779,844		1,691,333
Total assets less current liabilities		1,815,640		1,729,134
Net assets		1,815,640		1,729,134
Capital and reserves
Called up share capital		100		100
Profit and loss account		1,815,540		1,729,034
Shareholders' funds		1,815,640		1,729,134

The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.
The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved and authorised for issue by the Board of Directors on 21 September 2026, and are signed on its behalf by:

LUNN, John
Director

MINAEI MOGHADAM, Ali
Director

Registered Company No. 12966015

GR4VY LIMITED

Notes to the Financial Statements
for the year ended 31 December 2025

1.	Accounting policies

	Statutory information
	The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

	Statement of compliance
	The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

	Functional and presentation currency
	The financial statements are presented in sterling and this is the functional currency of the company.

	Employee benefits
	Contributions to defined contribution plans are expensed in the period to which they relate.

	Foreign currency translation
	Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

Foreign currency translation

Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

	Research and development
	Research expenditure is written off to the income statement in the year in which it is incurred. Development expenditure is written off in the same way unless the directors are satisfied that: - an individual project is technically, commercially and financially viable - a project gives rise to a separately identifiable asset and arises from contractual or other legal rights - it is probable that future economic benefits that are attributable to the project will follow to the company - the cost or value of the asset can be measured reliably If the above criteria are met, the expenditure is deferred and amortised over the period during which the company is expected to benefit.

Research and development

Research expenditure is written off to the income statement in the year in which it is incurred.
Development expenditure is written off in the same way unless the directors are satisfied that:

- an individual project is technically, commercially and financially viable
- a project gives rise to a separately identifiable asset and arises from contractual or other legal rights
- it is probable that future economic benefits that are attributable to the project will follow to the company
- the cost or value of the asset can be measured reliably 

If the above criteria are met, the expenditure is deferred and amortised over the period during which the company is expected to benefit.

2.	Average number of employees


		2025		2024
	Average number of employees during the year	16		16